Cited by 353Iron Metabolism and DisordersErythropoietin and Anemia TreatmentFerroptosis and cancer prognosis

Molecular control of iron transport

Ganz, Tomas·2007·Journal of the American Society of Nephrology

Abstract

The iron-regulatory hormone hepcidin is a 25-amino acid peptide that is synthesized in hepatocytes. Hepcidin binds to the cellular iron export channel ferroportin and causes its internalization and degradation and thereby decreases iron efflux from iron exporting tissues into plasma. By this mechanism, hepcidin inhibits dietary iron absorption, the efflux of recycled iron from splenic and hepatic macrophages, and the release of iron from storage in hepatocytes. Hepcidin synthesis is stimulated by plasma iron and iron stores and is inhibited by erythropoietic activity, ensuring that extracellular plasma iron concentrations and iron stores remain stable and the erythropoietic demand for iron is met. During inflammation, increased hepcidin concentrations cause iron sequestration in macrophages, resulting in hypoferremia and eventually anemia of inflammation. Hepcidin deficiency plays a central role in most iron overload disorders. The role of hepcidin abnormalities in anemias that are associated with renal disease and in resistance to erythropoietic therapies remains to be elucidated.

Integrity signals

Registry

Crossref · 10.1681/asn.2006070802

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated hepcidin leads to reduced ferroportin surface expression and hypoferremia.

    “and lead to reduced ferroportin surface expression and hypoferremia”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [188]

  • Hepcidin suppresses intestinal iron uptake and release of iron from internal stores by facilitating the degradation and internalization of ferroportin.

    “Hepcidin suppresses intestinal iron uptake and release of iron from internal stores by facilitating the degradation and internalization of the only known cellular iron exporter, ferroportin”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [188]

  • Hepcidin has a key role in the pathogenesis of anemia of chronic disease.

    “lending support to the notion that hepcidin has a key role in the pathogenesis of anemia of chronic disease.”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [188]

  • Chronically elevated serum hepcidin levels are frequently associated with inflammatory states.

    “Chronically elevated serum hepcidin levels are frequently associated with inflammatory states”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [188]

  • Interleukin-6 induces hepcidin transcription via JAK/STAT signaling.

    “(interleukin-6 induces hepcidin transcription via JAK/STAT signaling)”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [188]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ganz, T.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Ganz, Tomas
Venue
Journal of the American Society of Nephrology
Published
2007-02
Volume
18
Issue
2
Pages
394-400
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2120359196
Cited by
353
References
58
Citations by year
2026: 1 · 2025: 4 · 2024: 8 · 2023: 9 · 2022: 15 · 2021: 30 · 2020: 13 · 2019: 17 · 2018: 17 · 2017: 12 · 2016: 19 · 2015: 22 · 2014: 17 · 2013: 22 · 2012: 18
FWCI
23.00
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL046809, HL46809)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
Keywords
hepcidin, iron transport, ferroportin, iron homeostasis, dietary iron absorption, iron storage, erythropoiesis, inflammation, anemia of chronic disease, iron overload, anemia of chronic kidney disease
MeSH terms
Ferroportin, Anemia, Biological Transport, Bone and Bones, Homeostasis, Humans, Inflammation, Intestinal Absorption, Iron, Kidney Diseases, Kinetics, Liver, Iron Overload, Antimicrobial Cationic Peptides, Cation Transport Proteins, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review